EMBOLIZATION MARKET ANALYSIS

Embolization Market Size and Trends

Global embolization market is estimated to be valued at USD 2.21 Bn in 2024 and is expected to reach USD 3.88 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 8.4% from 2024 to 2031.

To learn more about this report, Request sample copy

The market growth is primarily driven by increasing prevalence of cardiovascular, oncology and neurological disorders worldwide. Embolization procedures are minimally-invasive, and are less painful for patients as compared to conventional open surgeries. This is expected to boost adoption of embolization processes in the near future.

Market players are constantly investing in research and development to launch newer and more effective embolic agents. Increasing application of these procedures for treating liver cancer and other tumors can offer growth opportunities. However, high cost of embolization procedures and lack of reimbursement policies in some emerging nations can hamper the market growth.

Rising incidences of cancer and cardiovascular diseases

Rising cases of cancer and cardiovascular diseases can drive the market growth. According to the World Health Organization, cardiovascular diseases are the number one cause of death globally, with an estimated 17.9 million deaths due to CVDs each year. Cancer also poses a major threat, with nearly 10 million new cases and 9.6 million deaths due to cancer in 2018. Advanced interventional procedures and minimally invasive treatment techniques have allowed physicians to treat these conditions. Embolization has emerged as a vital therapeutic option for treatment of cancerous and non-cancerous tumors as well as certain cardiovascular conditions. It is being widely used to restrict blood flow to tumors prior to surgery or radiation therapy, thus, aiding in their destruction. For cardiovascular applications, embolization treat aneurysms, uterine fibroids and arterial venous malformations by blocking blood supply to abnormal blood vessels. Growing prevalence of diseases , coupled with increasing adoption of minimally invasive procedures can boost demand for embolization devices and accessories. Global embolization market growth is driven by several factors, including increasing incidence of vascular diseases, advancements in embolization products and techniques, rising R&D efforts, and growing demand for minimally invasive treatments. For instance, in 2020, according to the World Health Organization, ischemic heart disease alone contributes to 16% of annual global deaths. Cardiovascular diseases cause around 17.9 million deaths worldwide each year, representing 35% of total global mortality. Out of these cardiovascular-related deaths, 85% are attributed to heart attacks and strokes. Ischemic heart disease is highlighted as a prominent cause of global mortality, affecting approximately 126 million individuals worldwide, and will increase to over 1,845 cases per 100,000 people by 2030. This underscores the significant impact of cardiovascular diseases, including coronary heart disease, rheumatic heart disease, cerebrovascular disease, and other cardiac conditions, as leading causes of death worldwide.

To learn more about this report, Request sample copy

Continued technological innovations

Continual technological innovations expand the clinical applications of embolization, thus, driving the market growth. Vendors are developing new product formulations, delivery technologies and advanced techniques that enhance procedural safety, efficiency and outcomes. For instance, new detachable coils allow for more targeted embolization of aneurysms and malformations. Advancements like microspheres and drug-eluting beads permit prolonged localized drug delivery post-embolization. Biosurgical thrombin  improves hemostasis during procedures. Improved imaging systems also assist in precise catheter navigation and placement. The availability of biocompatible materials allows for longer-term occlusion with reduced risks. Furthermore, vendors are exploring innovative methods like combination therapy and integration of embolic agents with diagnostic capabilities. Such technological advancements are supporting treatment of complex cases, improving success rates and enabling use of embolization in new clinical indications. These are likely to make embolization more effective and viable option for broader patient base over time, thus, driving the market growth.